[1] World Health Organization. Global tuberculosis reports 2023. World Health Organization. 2023.
[2] Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med, 2016; 13, e1002152. doi:  10.1371/journal.pmed.1002152
[3] World Health Organization. The end TB strategy. WHO. 2014. https://www.who.int/publications/i/item/WHO-HTM-TB-2015.19. [2024-06-03]
[4] Xu CH, Zhao YL. China's countermeasures in the context of Global Tuberculosis Prevention Action. Chin J Tuberc Respir Dis, 2022; 45, 308−12. (In Chinese)
[5] Cohen A, Mathiasen VD, Schön T, et al. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2019; 54, 1900655. doi:  10.1183/13993003.00655-2019
[6] World Health Organization. WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment. World Health Organization. 2020.
[7] Zenner D, Beer N, Harris RJ, et al. Treatment of latent tuberculosis infection: an updated network meta-analysis. Ann Intern Med, 2017; 167, 248−55. doi:  10.7326/M17-0609
[8] Houben RMGJ, Menzies NA, Sumner T, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Global Health, 2016; 4, e806−15. doi:  10.1016/S2214-109X(16)30199-1
[9] World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization. 2018.
[10] Gao L, Bai LQ, Liu JM, et al. Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J, 2016; 48, 168−78. doi:  10.1183/13993003.00235-2016
[11] Cui XJ, Gao L, Cao B. Management of latent tuberculosis infection in China: exploring solutions suitable for high-burden countries. Int J Infect Dis, 2020; 92S, S37−40.
[12] Chinese Center for Disease Control and Prevention. Technical guide for tuberculosis prevention and control in China. People's Medical Publishing House. 2021. (In Chinese)
[13] Chinese Center for Disease Control and Prevention. Technical guide for the preventive treatment of tuberculosis in China. People's Medical Publishing House. 2023. (In Chinese)
[14] Zhang J, Fu RN, Wang SL, et al. Analysis of willingness of receiving preventive treatment in patients with latent tuberculosis infection among close contacts of pulmonary tuberculosis in high-burden areas. Chin J Antituberc, 2024; 46, 165−72. (In Chinese)
[15] Li G, Xu H, Jing MY, et al. Reason analysis and countermeasure evaluation of latent tuberculosis infection refusing preventive treatment in a certain county. J Clin Pulm Med, 2022; 27, 1415−20. (In Chinese)
[16] Fa LF, Xu CH, Cheng J, et al. Acceptability of tuberculosis preventive treatment strategies among healthcare workers using an online survey-China, 2021. China CDC Wkly, 2022; 4, 211−5.
[17] Wang F, Ren YL, Liu K, et al. Large gap between attitude and action in tuberculosis preventive treatment among tuberculosis-related healthcare workers in eastern China. Front Cell Infect Microbial, 2022; 12, 991400. doi:  10.3389/fcimb.2022.991400
[18] National Bureau of Statistics. Major figures on 2020 population census of China. Office of the Leading Group of the State Council for the Seventh National Population Census. 2021. https://www.stats.gov.cn/sj/pcsj/rkpc/d7c/202303/P020230301403217959330.pdf. [2024-06-03]
[19] Yuan YM, Li SX, Zhou CC. Acceptance and influencing factors of preventive treatment for latent tuberculosis infection: a review. Chin J Public Health, 2023; 39, 942−7. (In Chinese)
[20] Almufty HB, Abdulrahman IS, Merza MA. Latent tuberculosis infection among healthcare workers in Duhok province: from screening to prophylactic treatment. Trop Med Infect Dis, 2019; 4, 85. doi:  10.3390/tropicalmed4020085
[21] Cao XL, Song ZX, He WC, et al. Tuberculosis screening characteristics amongst freshmen in Changping District, Beijing, China. BMC Infect Dis, 2023; 23, 869. doi:  10.1186/s12879-023-08802-y
[22] Wang Z, Li ZQ, Ding XY, et al. The current situation of willingness to receive prophylactic treatment among students with latent tuberculosis infection and its influencing factors in Jiangsu Province. China Trop Med, 2024; 24, 244−51. (In Chinese)
[23] Spruijt I, Haile DT, van den Hof S, et al. Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands. BMC Public Health, 2020; 20, 1602. doi:  10.1186/s12889-020-09697-z
[24] Gao J, Berry NS, Taylor D, et al. Knowledge and perceptions of latent tuberculosis infection among Chinese immigrants in a Canadian urban Centre. Int J Family Med, 2015; 2015, 546042.
[25] Manoharan A, Siti Nur Farhana H, Manimaran K, et al. Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study. BMC Infect Dis, 2023; 23, 624. doi:  10.1186/s12879-023-08612-2
[26] Spence BC, Bruxvoort K, Munoz-Plaza C, et al. Patient-reported barriers to treatment initiation and completion for latent tuberculosis infection among patients within a large integrated health care system in Southern California. J Public Health Manag Pract, 2023; 29, 345−52. doi:  10.1097/PHH.0000000000001711
[27] Hagger MS, Orbell S. The common-sense model of illness self-regulation: a conceptual review and proposed extended model. Health Psychol Rev, 2022; 16, 347−77. doi:  10.1080/17437199.2021.1878050